These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37541536)

  • 1. Chronic pain management in sickle cell disease: A systematic scoping review of controlled trials.
    Sidhom D; Aboul-Hassan D; Clauw DJ; Cofield C; Bergmans R
    Crit Rev Oncol Hematol; 2023 Oct; 190():104087. PubMed ID: 37541536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and emerging treatments for vaso-occlusive pain in sickle cell disease.
    Dampier C
    Expert Rev Hematol; 2019 Oct; 12(10):857-872. PubMed ID: 31364883
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease.
    Pal S; Dixit R; Moe S; Godinho MA; Abas AB; Ballas SK; Ram S; Yousuf UAM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012762. PubMed ID: 32124977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain in sickle cell disease: current and potential translational therapies.
    Sagi V; Mittal A; Tran H; Gupta K
    Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ;
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Chronic Pain and Opioid Usage in Adult Sickle Cell Disease Patients Referred to a Comprehensive Pain Clinic.
    Zoheiry N; Alkokani M; Ward R; Mailis A
    Pain Med; 2016 Nov; 17(11):2145-2146. PubMed ID: 27880652
    [No Abstract]   [Full Text] [Related]  

  • 11. Pain management for sickle cell disease.
    Dunlop RJ; Bennett KC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003350. PubMed ID: 16625580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle Cell Disease: A Review of Nonpharmacological Approaches for Pain.
    Williams H; Tanabe P
    J Pain Symptom Manage; 2016 Feb; 51(2):163-77. PubMed ID: 26596876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.
    Sagi V; Argueta DA; Kiven S; Gupta K
    Complement Ther Med; 2020 Jun; 51():102394. PubMed ID: 32507420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Review of the Treatment and Management of Pain in Sickle Cell Disease.
    Fiocchi J; Urits I; Orhurhu V; Orhurhu MS; Giacomazzi S; Hoyt B; Kaye AD; Kaye RJ; Viswanath O
    Curr Pain Headache Rep; 2020 Mar; 24(5):17. PubMed ID: 32200490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary evaluation of the clinical implementation of cognitive-behavioral therapy for chronic pain management in pediatric sickle cell disease.
    Sil S; Lai K; Lee JL; Gilleland Marchak J; Thompson B; Cohen L; Lane P; Dampier C
    Complement Ther Med; 2020 Mar; 49():102348. PubMed ID: 32147059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Pain Does Not Impact Baseline Circulating Cytokine Levels in Adults with Sickle Cell Disease.
    Karafin MS; Simpson P; Field JJ
    Acta Haematol; 2021; 144(1):111-116. PubMed ID: 32403100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Pain: Prevalence and Management.
    Carroll CP; Brandow AM
    Hematol Oncol Clin North Am; 2022 Dec; 36(6):1151-1165. PubMed ID: 36400536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?
    Nobrega R; Carullo V; Thein SL; Quezado ZMN
    Expert Rev Hematol; 2022 Oct; 15(10):887-891. PubMed ID: 36191299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five lessons learned about long-term pain management in adults with sickle cell disease.
    Field JJ
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):406-411. PubMed ID: 29222285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.